ARCHIVES

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

ORI Final Findings Of Scientific Misconduct

September 16, 1994

AACR Says 5 Percent Of Meeting Registrants Couldn’t Attend Due To Volcanic Ash In Europe

April 30, 2010

CREG Announced for Premorbid Psychological Factors Study

August 27, 1976

ACS Urged To Put More Resources Into Psychosocial Research

May 8, 1981

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014

Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say

May 14, 2010